AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barceló-Coblijn, G.
Right arrow Articles by Friel, J. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barceló-Coblijn, G.
Right arrow Articles by Friel, J. K
Agricola
Right arrow Articles by Barceló-Coblijn, G.
Right arrow Articles by Friel, J. K
American Journal of Clinical Nutrition, Vol. 88, No. 3, 801-809, September 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Flaxseed oil and fish-oil capsule consumption alters human red blood cell n–3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n–3 fatty acid1,2,3

Gwendolyn Barceló-Coblijn, Eric J Murphy, Rgia Othman, Mohammed H Moghadasian, Tarek Kashour and James K Friel

1 From the Departments of Pharmacology, Physiology, and Therapeutics (GB-C and EM) and Chemistry (EJM), University of North Dakota, Grand Forks, ND, and the Departments of Human Nutritional Sciences (MHM, RO, and JKF) and of Medicine and Biochemistry and Medical Genetics (TK), University of Manitoba, Winnipeg, Canada

Background: An increase in plasma n–3 fatty acid content, particularly eicosapentaenoic acid (20:5n–3; EPA) and docosahexaenoic acid (22:6n–3; DHA), is observed after consumption of fish oil–enriched supplements. Because {alpha}-linolenic acid (18:3n–3; ALA) is the direct precursor of EPA and DHA, ALA-enriched supplements such as flax may have a similar effect, although this hypothesis has been challenged because of reported low conversion of ALA into DHA.

Objective: To address this question, we designed a clinical trial in which flax oil, fish-oil, and sunflower oil (placebo group) capsules were given to firefighters (n = 62), a group traditionally exposed to cardiovascular disease risk factors.

Design: Firefighters were randomly divided into 6 experimental groups receiving 1.2, 2.4, or 3.6 g flax oil/d; 0.6 or 1.2 g fish oil/d; or 1 g sunflower oil/d for 12 wk. Blood was drawn every 2 wk, and the total phospholipid fatty acid composition of red blood cells was determined.

Results: As expected, fish oil produced a rapid increase in erythrocyte DHA and total n–3 fatty acids. The consumption of either 2.4 or 3.6 g flax oil/d (in capsules) was sufficient to significantly increase erythrocyte total phospholipid ALA, EPA, and docosapentaenoic acid (22:5n–3) fatty acid content. There were no differences among groups in plasma inflammatory markers or lipid profile.

Conclusions: The consumption of ALA-enriched supplements for 12 wk was sufficient to elevate erythrocyte EPA and docosapentaeoic acid content, which shows the effectiveness of ALA conversion and accretion into erythrocytes. The amounts of ALA required to obtain these effects are amounts that are easily achieved in the general population by dietary modification.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
A. Pan, D. Yu, W. Demark-Wahnefried, O. H Franco, and X. Lin
Meta-analysis of the effects of flaxseed interventions on blood lipids
Am. J. Clinical Nutrition, August 1, 2009; 90(2): 288 - 297.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition